UnitedHealth Group Net Worth
UnitedHealth Group Net Worth Breakdown | UNH |
UnitedHealth Group Net Worth Analysis
UnitedHealth Group's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including UnitedHealth Group's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of UnitedHealth Group's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform UnitedHealth Group's net worth analysis. One common approach is to calculate UnitedHealth Group's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares UnitedHealth Group's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing UnitedHealth Group's net worth. This approach calculates the present value of UnitedHealth Group's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of UnitedHealth Group's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate UnitedHealth Group's net worth. This involves comparing UnitedHealth Group's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into UnitedHealth Group's net worth relative to its peers.
To determine if UnitedHealth Group is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding UnitedHealth Group's net worth research are outlined below:
| UnitedHealth Group Incorporated has 67.44 B in debt with debt to equity (D/E) ratio of 0.59, which is OK given its current industry classification. UnitedHealth Group has a current ratio of 0.76, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for UnitedHealth to invest in growth at high rates of return. | |
| Over 90.0% of UnitedHealth Group outstanding shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: CFS Investment Advisory Services LLC Purchases 272 Shares of UnitedHealth Group Incorporated |
UnitedHealth Group Quarterly Good Will |
|
UnitedHealth Group uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in UnitedHealth Group Incorporated. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to UnitedHealth Group's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of April 2024 Upcoming Quarterly Report | View | |
| 12th of July 2024 Next Financial Report | View | |
| 31st of March 2024 Next Fiscal Quarter End | View | |
| 10th of January 2025 Next Fiscal Year End | View | |
| 31st of December 2023 Last Quarter Report | View | |
| 31st of December 2023 Last Financial Announcement | View |
Know UnitedHealth Group's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as UnitedHealth Group is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading UnitedHealth Group Incorporated backward and forwards among themselves. UnitedHealth Group's institutional investor refers to the entity that pools money to purchase UnitedHealth Group's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Capital Research & Mgmt Co - Division 3 | 2024-09-30 | 14.7 M | Norges Bank | 2024-06-30 | 11.7 M | Royal Bank Of Canada | 2024-06-30 | 8.5 M | Northern Trust Corp | 2024-09-30 | 8.4 M | Legal & General Group Plc | 2024-06-30 | 8.3 M | Franklin Resources Inc | 2024-09-30 | 8.2 M | Wells Fargo & Co | 2024-06-30 | 8.2 M | Bank Of New York Mellon Corp | 2024-06-30 | 8 M | Alliancebernstein L.p. | 2024-06-30 | 7.9 M | Vanguard Group Inc | 2024-09-30 | 85 M | Blackrock Inc | 2024-06-30 | 73.4 M |
Follow UnitedHealth Group's market capitalization trends
The company currently falls under 'Mega-Cap' category with a total capitalization of 543.77 B.Project UnitedHealth Group's profitablity
The company has Net Profit Margin of 0.04 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.09 %, which entails that for every 100 dollars of revenue, it generated $0.09 of operating income.When accessing UnitedHealth Group's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures UnitedHealth Group's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of UnitedHealth Group's profitability and make more informed investment decisions.
Evaluate UnitedHealth Group's management efficiency
UnitedHealth Group has Return on Asset of 0.0692 % which means that on every $100 spent on assets, it made $0.0692 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1525 %, implying that it generated $0.1525 on every 100 dollars invested. UnitedHealth Group's management efficiency ratios could be used to measure how well UnitedHealth Group manages its routine affairs as well as how well it operates its assets and liabilities.Leadership effectiveness at UnitedHealth Group Incorporated is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Enterprise Value Revenue 1.5027 | Revenue 393.9 B | Quarterly Revenue Growth 0.092 | Revenue Per Share 427.221 | Return On Equity 0.1525 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific UnitedHealth Group insiders, such as employees or executives, is commonly permitted as long as it does not rely on UnitedHealth Group's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases UnitedHealth Group insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cianfrocco Heather over three months ago Disposition of 10712 shares by Cianfrocco Heather of UnitedHealth Group at 327.64 subject to Rule 16b-3 | ||
Andrew Witty over a year ago Payment of 372 shares by Andrew Witty of UnitedHealth Group subject to Rule 16b-3 | ||
Andrew Witty over a year ago Acquisition by Andrew Witty of 100 shares of UnitedHealth Group subject to Rule 16b-3 |
UnitedHealth Group Corporate Filings
F4 | 15th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 4th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 15th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
FWP | 24th of July 2024 A written communication used by offering participants to offer securities to the public or to solicit securities transactions. | ViewVerify |
UnitedHealth Group Earnings per Share Projection vs Actual
UnitedHealth Group Corporate Directors
| Gail Wilensky | Independent Director | Profile | |
| Valerie Rice | Independent Director | Profile | |
| John Noseworthy | Independent Director | Profile | |
| William Ballard | Independent Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.043 | Dividend Share 7.96 | Earnings Share 15.36 | Revenue Per Share 427.221 | Quarterly Revenue Growth 0.092 |
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.